Eyenuk’s AI screening program detects referable diabetic retinopathy

KOLOA, Hawaii — Artificial intelligence can play a role in meeting the significant need for diabetic retinopathy screening in the US, where more than 30 million adults have the disease and only half of them obtain yearly eye screenings, Michael S. Ip, MD, said in a presentation here at Retina 2020.
The EyeArt AI screening and referral workflow system (Eyenuk), which is limited to investigational use in the US, has undergone “rigorous clinical validation” in retrospective studies, according to Ip. Of more than 100,000 consecutive patient visits, the software sensitivity (Read more...)

Full Story →